Table 1.
Characteristic | n = 195 |
---|---|
Demographics | |
Mean age ± SD in years (range) | 31.3 ± 5.2 (18–43) |
Median gravity/parity (range) | 3/1 (1–13/0–8) |
History of medical conditions, n (%) | 74 (37.9) |
Gestational diabetes | 24 (12) |
Hypertension | 22 (11) |
Hypothyroidism | 12 (6) |
Asthma | 12 (6) |
Antepartum ASA use, n (%) | 38 (19) |
Anticoagulation | |
Antepartum only | 6 (3) |
Antepartum and postpartum | 156 (80) |
Postpartum only | 33 (17) |
Delivery Information | |
Mean gestational age ± SD in weeks (range) | 37.7 ± 3.4 (23.1–41.7) |
Mode of delivery, n (%) | |
Vaginal | 122 (63) |
Cesarean | 73 (37) |
Labor induction, n (%) | 83 (43) |
Neuraxial anesthesia, n (%) | 113 (58) |
Oxytocic agent used, n (%) | 188 (96) |
Mean duration of stages I–III (h:mm ± SD) (range) | |
Stage I | 6:09 ± 3:47 (0:20–18:45) |
Stage II | 0:53 ± 1:01 (0:01–5:15) |
Stage III | 0:05 ± 0:08 (0:00–1:42) |
SD: standard deviation; ASA: acetylsalicylic acid; h: hours; mm: minutes.